| P2093 | author name string | Noori Akhtar-Danesh | |
| | Ashok Malla | |
| | Robert B Zipursky | |
| | Ross Norman | |
| | Paul Roy | |
| | Brian R Rush | |
| | Suzanne Archie | |
| P2860 | cites work | Causal association between cannabis and psychosis: examination of the evidence | Q28241735 |
| | Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption--II | Q28260514 |
| | Low-risk drinking guidelines: the scientific evidence. | Q33734096 |
| | Psychosocial approaches to dual diagnosis | Q33886044 |
| | Early detection and intervention in first-episode schizophrenia: a critical review | Q33948803 |
| | Phencyclidine (PCP): a dangerous drug, but useful in schizophrenia research | Q34147040 |
| | The drug abuse screening test | Q34280814 |
| | Morbid risk for psychiatric disorder among the relatives of methamphetamine users with and without psychosis | Q34418687 |
| | Improving 1-year outcome in first-episode psychosis: OPUS trial | Q34438810 |
| | The Structured Clinical Interview for DSM-III-R (SCID). II. Multisite test-retest reliability | Q34478953 |
| | Cannabis, vulnerability, and the onset of schizophrenia: an epidemiological perspective | Q34509505 |
| | Precipitation and determination of the onset and course of schizophrenia by substance abuse--a retrospective and prospective study of 232 population-based first illness episodes | Q34522385 |
| | Cannabis use and age at onset of schizophrenia | Q34545981 |
| | Pharmacological management of first-episode schizophrenia and related nonaffective psychoses | Q35549773 |
| | The role of family work in early psychosis | Q36273893 |
| | What are the policy implications of the evidence on cannabis and psychosis? | Q36606248 |
| | A randomized clinical trial of supported employment for inner-city patients with severe mental disorders | Q39512379 |
| | Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study | Q39680990 |
| | Comorbid substance use and age at onset of schizophrenia | Q39747250 |
| | The Structured Clinical Interview for DSM-III-R (SCID). I: History, rationale, and description | Q41128285 |
| | The association between psychosis and problematical drug use among Australian adults: findings from the National Survey of Mental Health and Well-Being | Q43607237 |
| | Diagnostic validity of the drug abuse screening test in the assessment of DSM-III drug disorders | Q43628528 |
| | A community intervention for early identification of first episode psychosis: impact on duration of untreated psychosis (DUP) and patient characteristics | Q43776701 |
| | Five-year outcomes of a brief alcohol intervention for adult in-patients with psychiatric disorders | Q44520306 |
| | Substance misuse at presentation to an early psychosis program | Q44800166 |
| | Cannabis use and psychosis: a longitudinal population-based study. | Q44820509 |
| | A brief motivational intervention for substance misuse in recent-onset psychosis | Q45060877 |
| | The Danish National Schizophrenia Project: prospective, comparative longitudinal treatment study of first-episode psychosis | Q46465922 |
| | The impact of substance use disorders on clinical outcome in 643 patients with first-episode psychosis | Q46578593 |
| | Is adolescent-onset first-episode psychosis different from adult onset? | Q46611016 |
| | The AUDIT-C: screening for alcohol use disorders and risk drinking in the presence of other psychiatric disorders | Q46794584 |
| | The association between moderate alcohol use and illness severity in bipolar disorder: a preliminary report | Q46903470 |
| | Status of patients with first-episode psychosis after one year of phase-specific community-oriented treatment | Q47571407 |
| | Susceptibility to subsequent episodes in spontaneous recurrence of methamphetamine psychosis. | Q51073176 |
| | Substance misuse in first-episode psychosis: 15-month prospective follow-up study. | Q51913084 |
| | Lifetime positive symptoms in patients with schizophrenia and cannabis abuse are partially explained by co-morbid addiction. | Q51915513 |
| | The Canadian Community Health Survey: mental health and well-being. | Q51924340 |
| | Psychotic disorders clinic and first-episode psychosis: a program evaluation. | Q51932402 |
| | Duration of untreated psychosis and pathways to care in first-episode psychosis. Investigation of help-seeking behaviour in primary care. | Q51953143 |
| | Aggressive incidents in first-episode psychosis. | Q51967198 |
| | An examination of the utility of the AUDIT in people with schizophrenia. | Q51973238 |
| | Use of the AUDIT and the DAST-10 to identify alcohol and drug use disorders among adults with a severe and persistent mental illness | Q73974036 |
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | psychosis | Q170082 |
| | substance P | Q411041 |
| P304 | page(s) | 1354-1363 | |
| P577 | publication date | 2007-03-03 | |
| P1433 | published in | Schizophrenia Bulletin | Q4049133 |
| P1476 | title | Substance use and abuse in first-episode psychosis: prevalence before and after early intervention | |
| P478 | volume | 33 | |